553 related articles for article (PubMed ID: 16762629)
1. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease.
Danese S; Scaldaferri F; Vetrano S; Stefanelli T; Graziani C; Repici A; Ricci R; Straface G; Sgambato A; Malesci A; Fiocchi C; Rutella S
Gut; 2007 Sep; 56(9):1248-56. PubMed ID: 17317789
[TBL] [Abstract][Full Text] [Related]
7. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
8. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Hebler U; Voigt E; Tromm A; May B
Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
Chidlow JH; Shukla D; Grisham MB; Kevil CG
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease.
Konno S; Iizuka M; Yukawa M; Sasaki K; Sato A; Horie Y; Nanjo H; Fukushima T; Watanabe S
J Gastroenterol; 2004 Oct; 39(10):931-9. PubMed ID: 15549445
[TBL] [Abstract][Full Text] [Related]
13. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease.
Horowitz S; Binion DG; Nelson VM; Kanaa Y; Javadi P; Lazarova Z; Andrekopoulos C; Kalyanaraman B; Otterson MF; Rafiee P
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1323-36. PubMed ID: 17218473
[TBL] [Abstract][Full Text] [Related]
14. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease.
Rutella S; Fiorino G; Vetrano S; Correale C; Spinelli A; Pagano N; Arena V; Maggiano N; Repici A; Malesci A; Danese S
Am J Gastroenterol; 2011 Apr; 106(4):762-70. PubMed ID: 21364546
[TBL] [Abstract][Full Text] [Related]
15. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
Danese S
Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
[TBL] [Abstract][Full Text] [Related]
17. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
18. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease.
Goebel S; Huang M; Davis WC; Jennings M; Siahaan TJ; Alexander JS; Kevil CG
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G648-54. PubMed ID: 16293653
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in inflammatory bowel disease.
Pousa ID; Maté J; Gisbert JP
Eur J Clin Invest; 2008 Feb; 38(2):73-81. PubMed ID: 18226040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
